Showing 1 - 10 of 454
Persistent link: https://www.econbiz.de/10003897672
Persistent link: https://www.econbiz.de/10008316612
The pharmaceutical industry is a textbook example of a science based sector characterized by high R&D cost, uncertain and spillovers for which patent protection assures appropriability thus providing incentives for innovation. Indeed, Mansfield (1986) found that, absent patent protection, 60...
Persistent link: https://www.econbiz.de/10014216850
The prominent role played by patents within the pharmaceutical domain is unquestionable. In this paper, we focus on a relatively neglected implication of patents: the effect of patent-induced information disclosure on the dynamics of R&D and market competition. The study builds upon the...
Persistent link: https://www.econbiz.de/10004966691
The prominent role played by patents within the pharmaceutical domain is unquestionable. In this paper we take an unusual perspective and focus on a relatively neglected implication of patents: the effect of patent-induced information disclosure (of both successes and failures) on the dynamics...
Persistent link: https://www.econbiz.de/10005061430
The prominent role played by patents within the pharmaceutical domain is unquestionable. In this paper we take an unusual perspective and focus on a relatively neglected implication of patents: the effect of patent-induced information disclosure (of both successes and failures) on the dynamics...
Persistent link: https://www.econbiz.de/10005036133
Persistent link: https://www.econbiz.de/10009658375
Persistent link: https://www.econbiz.de/10011477734
Persistent link: https://www.econbiz.de/10011590738
During the last 30 years, health care expenditure (HCE) has been growing much more rapidly than GDP in OECD countries. In this paper, we review the determinants of HCE dynamics in Europe, taking into account the role of income, aging population, technological progress, female labor...
Persistent link: https://www.econbiz.de/10010993849